📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
206 analysed today
FollowTelegram
206
Today
149,607
All-time analysed
42,901
Positive
6,659
Negative
91,372
Neutral
8,607
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
22 announcements match the current filters (relevance ≥ 5).
RMCL Clarifies Phytoatomy Private Limited Acquisition Still Under Process
Radha Madhav Corporation Limited (RMCL) has issued a clarification regarding its proposed acquisition of a majority stake in Phytoatomy Private Limited, which was initially announced on November 4, 2023. The company stated that as of January 23, 2026, the acquisition process is still ongoing and has not yet been completed. Consequently, RMCL has not yet acquired any control or shareholding in the target company. This update highlights a significant delay of over two years since the original proposal was made.
Key Highlights
Proposed acquisition of majority stake in Phytoatomy Private Limited remains incomplete as of January 23, 2026.
Initial intimation for the acquisition was provided over 26 months ago on November 4, 2023.
RMCL currently holds zero control or shareholding in Phytoatomy Private Limited.
The company clarified the status in response to regulatory requirements for general updates.
👀 What to Watch
Investors should exercise caution as the prolonged delay in completing the acquisition may indicate regulatory or financial hurdles. Monitor for further disclosures regarding the finalization or termination of this deal.
RMCL Provides Update on Pending Acquisition of Phytoatomy Private Limited
Radha Madhav Corporation Limited (RMCL) has issued a clarification regarding its proposed acquisition of a majority stake in Phytoatomy Private Limited. The company stated that the acquisition process, which was first announced on November 4, 2023, is still ongoing and has not been completed as of January 23, 2026. Consequently, RMCL currently holds no shareholding or control in the target entity. This update highlights a significant delay of over two years in the execution of the deal.
Key Highlights
Proposed acquisition of majority stake in Phytoatomy Private Limited remains in process since November 2023.
RMCL confirms it has not yet acquired any control or shareholding in the target company.
The deal has been pending for approximately 26 months without finalization.
The clarification was issued to stock exchanges to update the current status of the transaction.
👀 What to Watch
Investors should remain cautious as the prolonged delay in completing the acquisition may indicate execution challenges or regulatory hurdles. Monitor for a definitive timeline or a potential cancellation of the deal in future filings.
